Please assess the completion status of the following clinical trial:

Trial Title: A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient must have achieved complete clearance of AK lesions (lesion count = 0) at Day 57 in one of the following Peplin AK clinical studies: PEP005-016 or PEP005-025~* Patient has provided informed consent documented by signing the Informed Consent Form (ICF) prior to any study-related procedures~Exclusion Criteria:~* Concurrent participation in another research study which would involve the selected treatment area (except for any post-study follow-up visits for previous Peplin AK study)~* Early termination from study PEP005-016 or PEP005-025

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).